3592
G. Savitha, P. T. Perumal / Tetrahedron Letters 47 (2006) 3589–3593
Lacova, M.; Stankovicova, H. Biol. Plant. 1995, 38, 397;
References and notes
(m) Pauls, H. W.; Ewing, W. R.; Choi-Sledeoki, Y. M.
Frontiers Med. Chem.-Online 2004, 1, 129.
1. (a) Witherup, K. M.; Ransom, R. W.; Varga, S. L;
Pitzenberger, S. M.; Lotti, V. J; Lumma, W. J. U.S. Patent
US 5288725, 1994; Chem. Abstr. 1994, 121, 91779s; (b)
Perry, N. B.; Blunt, J. W.; McCombs, J. D.; Munro, M. H.
G. J. Org. Chem. 1986, 51, 5476; (c) Williamson, N. M.;
March, D. R.; Ward, A. D. Tetrahedron Lett. 1995, 36,
7721; (d) Johnson, J. V.; Rauckman, B. S.; Baccanari, D.
P.; Roth, B. J. Med. Chem. 1989, 32, 1942; (e) Carling, R.
W.; Leeson, P. D.; Moseley, A. M.; Baker, R.; Foster, A.
C.; Grimwood, S.; Kemp, J. A.; Marshall, G. R. J. Med.
Chem. 1992, 35, 1942; (f) Carling, R. W.; Leeson, P. D.;
Moseley, A. M.; Smith, J. D.; Saywell, K.; Tricklebank,
M. D.; Kemp, J. A.; Marshall, G. R.; Foster, A. C.;
Grimwood, S. Bioorg. Med. Chem. Lett. 1993, 3, 65; (g)
Hanada, K.; Furuya, K.; Inoguchi, K.; Miyakawa, M.;
Nagata, N. PCT Int. Appl. WO 0127086, 2001; Chem.
Abstr. 2001, 134, 295752.
9. Zulfiqar, F.; Kitazume, T. Green Chem. 2000, 2, 137.
10. (a) Hewe, J. R.; Chen, K.-L.; Anahan, S. J. Chem. Soc.,
Chem. Commun. 1994, 1425; (b) Reddy, M. V. R.;
Malhotra, B.; Vanker, Y. D. Tetrahedron Lett. 1995, 36,
486; (c) Manzo, E.; Barone, G.; Bedini, E.; Iadonisi, A.;
Mangoni, L.; Parrilli, M. Tetrahedron 2002, 58, 129; (d)
Goswami, P.; Chowdhury, P. New J. Chem. 2000, 24, 955;
(e) Zeng, X.-F.; Ji, S.-J.; Wang, S.-Y. Tetrahedron 2005,
61, 10235.
11. (a) Crousse, B.; Begue, J.-P.; Bonnet-Delpon, D. Tetra-
hedron Lett. 1998, 39, 5765; (b) Gadhwal, S.; Sandhu, J. S.
J. Chem. Soc., Perkin Trans. 1 2000, 2827.
12. General procedure: Synthesis of tetrahydroquinoline 4b
(Scheme 1). A mixture of 1b (0.128 g, 1 mmol), 2a (0.192 g,
1 mmol) and 3 (0.11 g, 1 mmol) was stirred in water
(5 mL)–acetonitrile (5 mL) in the presence of CAN
(0.027 g, 0.049 mmol, 5 mol %) at rt for 50 min until
completion of the reaction as followed by TLC. Water was
added to the mixture and the product was extracted into
ethyl acetate (2 · 20 mL) and the extract was dried over
anhydrous sodium sulfate. Removal of the solvent under
reduced pressure gave the crude product, which was
further purified by column chromatography on silica gel,
ethyl acetate–hexane (6:4) as eluent, to afford the pure
product 0.337 g (82%).
2. Mohamed, E. A. Chem. Pap. 1994, 48, 261; Chem. Abstr.
1995, 123, 9315.
3. (a) Leeson, P. D.; Carling, R. W.; Moore, K. W.; Moseley,
A. M.; Smith, J. D.; Stevenson, G.; Chan, T.; Baker, R.;
Foster, A. C.; Grimwood, S.; Kemp, J. A.; Marshall, G.
R.; Hoogsteen, K. J. Med. Chem. 1992, 35, 1954; (b)
Nagata, R.; Tanno, N.; Kodo, T.; Ae, N.; Yamaguchi, H.;
Nishimura, T.; Antoku, F.; Tatsuno, T.; Kato, T.;
Tanaka, Y.; Nakamura, M. J. Med. Chem. 1994, 37,
3956; (c) Guo, F.; Chang, B. H.; Rizzo, C. J. Bioorg. Med.
Chem. Lett. 2002, 12, 151; (d) Stanton, J. L.; Ackerman,
M. H. J. Med. Chem. 1983, 26, 986.
4. (a) Katritzky, A. R.; Rachwal, S.; Rachwal, B. Tetra-
hedron 1996, 52, 15031; (b) Yadav, J. S.; Reddy, B. V. S.;
Sunitha, V.; Reddy, K. S.; Ramakrishna, K. V. S.
Tetrahedron Lett. 2004, 45, 7947; (c) Powell, D. A.; Batey,
R. A. Tetrahedron Lett. 2003, 44, 7569; (d) Spanedda, M.
V.; Hoang, V. D.; Crousse, B.; Bonnet-Delpon, D.; Begue,
J.-P. Tetrahedron Lett. 2003, 44, 217.
5. (a) Larock, R. C.; Yang, H.; Pace, P. Tetrahedron Lett.
1998, 39, 1885; (b) Padwa, A.; Brodney, M. A.; Liu, B.;
Satake, K.; Wu, T. J. Org. Chem. 1999, 64, 3595; (c)
Bunce, R. A.; Herron, D. M.; Johnson, L. B.; Kotturi, S.
J. Org. Chem. 2001, 66, 2822; (d) Zhang, W.; Guo, Y.; Liu,
Z.; Jin, X.; Yang, L.; Liu, Z.-L. Tetrahedron 2005, 61,
1325.
Spectral values for selected compounds. Compound 4b
(Table 1): mp 287 ꢁC; mmax (KBr): 3351, 1660 cmÀ1 1H
;
NMR (500 MHz, CDCl3): d 1.89–1.96 (m, 1H), 2.01–2.04
(m, 2H), 2.29–2.34 (m, 1H), 2.43–2.57 (m, 2H), 3.14–3.18
(m, 1H), 3.22–3.27 (dd, 1H, J1 = 7.65 Hz, J2 = 16.85 Hz),
4.58 (br s, 1H, NH), 4.82–4.85 (d, 1H, J = 10.7 Hz), 5.67–
5.70 (dd, 1H, J1 = 6.15 Hz, J2 = 11.45 Hz), 6.58 (d, 1H,
J = 8.4 Hz), 6.78 (s, 1H), 6.95–6.97 (d, 1H, J = 8.4 Hz),
7.13–7.16 (t, 1H, J = 7.65 Hz), 7.35–7.42 (m, 2H), 7.47–
7.48 (d, 1H, J = 7.6 Hz), 7.87 (s, 1H). 13C NMR
(125 MHz, CDCl3): d 18.3, 31.3, 42.4, 48.2, 49.7, 49.8,
115.8, 116.9, 119.7, 121.0, 122.8, 123.1, 126.3, 127.9, 128.3,
132.9, 133.2, 135.7, 137.7, 144.7, 163.3, 176.0. MS m/z
(%) = 412 M+. Anal. Calcd for C22H19Cl2N3O (412.311):
C, 64.09; H, 4.64; N, 10.19. Found: C, 64.18; H, 4.56; N,
10.0.
Compound 4f (Table 1): mp 118 ꢁC; mmax (KBr): 3245,
1672, 1642 cmÀ1 1H NMR (500 MHz, CDCl3): d 1.93–
;
6. Kobayashi, S.; Nagayama, S. J. Am. Chem. Soc. 1996,
118, 8977.
7. Waldrogel, S. R.; Cepanec, I. Synthesis of Biaryls;
Elsevier: Amsterdam, 2004; p 368.
2.00 (m, 3H), 2.18 (s, 3H), 2.24–2.30 (m, 1H), 2.39–2.54
(m, 2H), 3.13–3.15 (m, 1H), 3.20–3.22 (m, 1H), 4.47 (br s,
1H, NH), 4.73–4.75 (d, 1H, J = 9.95 Hz), 5.65–5.67 (dd,
1H, J1 = 6.1 Hz, J2 = 12.25 Hz), 6.52–6.53 (d, 1H,
J = 8.4 Hz), 6.63 (s, 1H), 6.82–6.83 (d, 1H, J = 7.65 Hz),
7.35–7.38 (t, 1H, J = 7.65 Hz), 7.41–7.43 (d, 1H,
J = 8.4 Hz), 7.62–7.65 (m, 1H), 8.04 (s, 1H), 8.16–8.18
(m, 1H).13C NMR (125 MHz, CDCl3): d 18.3, 20.7, 31.5,
31.5, 42.4, 48.0, 48.1, 116.2, 118.2, 119.6, 123.8, 125.3,
125.4, 125.9, 127.1, 128.2, 129.0, 133.9, 143.4, 153.1, 156.2,
175.8, 177.0. MS m/z (%) = 374 M+. Anal. Calcd for
C23H22N2O3 (374.432): C, 73.78; H, 5.92; N, 7.48. Found:
C, 73.74; H, 5.98; N, 7.50.
8. (a) Dewick, P. M. In The Flavonoids: Advances in Research
Since 1986; Harborne, J. B., Ed.; Chapmann & Hall: New
York, 1994; p 23; (b) Gill, M. In The Chemistry of Natural
Products; 2nd ed.; Thomson, R. H., Ed.; Blackie: Surrey,
1993; p 60; (c) Flavonoids in the Living Systems: Advances
in Experimental Medicine and Biology; Manthey, J. A.,
Buslig, B. S., Eds.; Plenum: New York, 1998; Vol. 439; (d)
Wilkinson, D. M. Ecology Lett. 1999, 2, 207; (e) Grigg, R.;
Thornton-Pett, M.; Xu, J.; Xe, L. H. Tetrahedron 1999,
13841; (f) Vaccaro, W. D.; Daris, H. R., Jr. Bioorg. Med.
Chem. Lett. 1998, 8, 313; (g) Vaccaro, W. D.; Sher, R.;
Davis, H. R., Jr. Bioorg. Med. Chem. Lett. 1998, 8, 35; (h)
Burnett, D. A. Tetrahedron Lett. 1994, 35, 7339; (i)
Borthwick, A. D.; Weingarte, G.; Haley, T. M.; Tome-
szewski, M.; Wang, W.; Hu, Z.; Bedard, J.; Jin, H.; Yuen,
L.; Mansour, T. S. Bioorg. Med. Chem. Lett. 1998, 8, 365;
(j) Han, W. T.; Trehan, A. K.; Wright, J. J. K.; Federici,
M. E.; Seiler, S. M.; Meanwell, N. A. Bioorg. Med. Chem.
1995, 3, 1123; (k) Nohara, A.; Umetani, T.; Sanno, Y.
Tetrahedron 1974, 30, 3553; (l) Kralova, K.; Sersen, F.;
Compound 4h (Table 1): mp 56 ꢁC; mmax (KBr): 3330,
1670 cmÀ1 1H NMR (500 MHz, CDCl3): d 1.96–2.00
;
(m, 2H), 2.13–2.20 (m, 2H), 2.40–2.50 (m, 2H), 3.13–3.23
(m, 2H), 4.20 (br s, 1H, NH), 4.87 (dd, 1H, J1 = 7.45 Hz,
J2 = 11.3 Hz), 5.68 (dd, 1H, J1 = 6.3 Hz, J2 = 11.45 Hz),
6.56 (d, 1H, J = 8 Hz), 6.60–6.70 (t, 1H, J = 7.45 Hz), 6.84
(d, 1H, J = 8.05 Hz), 6.96 (m, 1H), 7.00 (m, 2H), 7.20
(d, 1H, J = 5.15 Hz). 13C NMR (125 MHz, CDCl3): d
18.3, 31.4, 36.2, 42.4, 48.2, 52.2, 115.3, 118.7, 119.0, 124.2,
124.3, 124.4, 126.8, 126.8, 145.4, 146.9, 175.9. MS